Klingbeil, K.D.; Tang, J.P.; Graham, D.S.; Lofftus, S.Y.; Jaiswal, A.K.; Lin, T.L.; Frias, C.; Chen, L.Y.; Nakasaki, M.; Dry, S.M.;
et al. IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma. Cancers 2023, 15, 4489.
https://doi.org/10.3390/cancers15184489
AMA Style
Klingbeil KD, Tang JP, Graham DS, Lofftus SY, Jaiswal AK, Lin TL, Frias C, Chen LY, Nakasaki M, Dry SM,
et al. IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma. Cancers. 2023; 15(18):4489.
https://doi.org/10.3390/cancers15184489
Chicago/Turabian Style
Klingbeil, Kyle D., Jack Pengfei Tang, Danielle S. Graham, Serena Y. Lofftus, Amit Kumar Jaiswal, Tasha L. Lin, Chris Frias, Lucia Y. Chen, Manando Nakasaki, Sarah M. Dry,
and et al. 2023. "IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma" Cancers 15, no. 18: 4489.
https://doi.org/10.3390/cancers15184489
APA Style
Klingbeil, K. D., Tang, J. P., Graham, D. S., Lofftus, S. Y., Jaiswal, A. K., Lin, T. L., Frias, C., Chen, L. Y., Nakasaki, M., Dry, S. M., Crompton, J. G., Eilber, F. C., Rao, D. S., Kalbasi, A., & Kadera, B. E.
(2023). IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma. Cancers, 15(18), 4489.
https://doi.org/10.3390/cancers15184489
